HERON THERAPEUTICS, INC. /DE/ - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 26, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HERON THERAPEUTICS, INC. /DE/Financial_Report.xls
EX-32 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - HERON THERAPEUTICS, INC. /DE/d316794dex32.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-15(E) - HERON THERAPEUTICS, INC. /DE/d316794dex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-15(E) - HERON THERAPEUTICS, INC. /DE/d316794dex312.htm
10-K - FORM 10-K - HERON THERAPEUTICS, INC. /DE/d316794d10k.htm

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement on Form S-3 (Nos. 333-162968 and 333-167890) and the Registration Statements on Form S-8 (Nos. 333-06841, 333-35151, 333-60585, 333-90428, 333-118546, 333-127574, 333-137954, 333-148660, 333-152862, 333-162610, 333-167515, 333-176365 and 333-176366) of our report dated March 23, 2012 with respect to the financial statements and schedule of A.P. Pharma, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2011.

 

/s/ OUM & CO. LLP
San Francisco, California
March 23, 2012

HERON THERAPEUTICS, INC. /DE/ Reports